Retour

Alcon Inc.

Qualité des données : 100%

ALC

NYSE Healthcare Medical - Instruments & Supplies

75,26 €

▲ 1,02 € (1,37%)

Cap. Boursière : 36,68B

Fourchette du Jour

73,99 € 75,50 €

Fourchette 52 Semaines

71,55 € 99,20 €

Volume

922 556

Moyenne 50J / 200J

80,51 € / 80,90 €

Clôture Précédente

74,24 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique	Action	Médiane du Secteur
P/E	37,4	0,2
P/B	1,7	3,0
ROE %	4,5	3,6
Net Margin %	9,4	3,8
Rev Growth 5Y %	5,8	9,9
D/E	0,2	0,2

Objectif de Cours des Analystes

Hold

91,02 € +20.9%

Low: 80,00 € High: 101,09 €

P/E Prévisionnel

22,40

BPA Prévisionnel

3,36 €

Croissance BPA (est.)

+0,0%

CA Est.

10,98B

Estimations de Bénéfices

Période	BPA Est.	CA Est.	Analystes
FY2030	5,56 € 5,46 € – 5,68 €	14,05B	5
FY2029	4,97 € 4,87 € – 5,07 €	13,14B	10
FY2028	4,37 € 2,91 € – 5,43 €	12,40B	12

Earnings Surprises

Last 8 quarters

Quarter	Est. EPS	Actual EPS	Surprise
2026-02-24	0,79 €	0,78 €	-1,3%
2025-11-11	0,77 €	0,79 €	+2,6%
2025-08-19	0,71 €	0,76 €	+7,0%
2025-05-13	0,76 €	0,73 €	-3,9%
2025-02-25	0,70 €	0,72 €	+2,9%
2024-11-12	0,72 €	0,81 €	+12,5%
2024-08-20	0,74 €	0,74 €	0,0%
2024-05-13	0,72 €	0,78 €	+8,3%

Dividend History

5 yr streak

Yield

0,00%

Payout Ratio

0,17%

Growth (3Y)

17,60%

Growth (5Y)

N/A

Ex-Date	Payment Date	Amount	Yield
May 13, 2025	May 15, 2025	0,33 €	0,36%
May 14, 2024	May 16, 2024	0,26 €	0,30%
May 10, 2023	May 12, 2023	0,24 €	0,29%
May 03, 2022	May 05, 2022	0,21 €	0,29%
May 04, 2021	May 06, 2021	0,10 €	0,15%

Points Clés

Revenue grew 5,83% annually over 5 years — modest growth

ROE of 4,50% is below average

Debt/Equity of 0,24 — conservative balance sheet

Generating 1,73B in free cash flow

P/E of 37,43 — premium valuation

Cash machine — converts 176,33% of earnings into free cash flow

Croissance

Revenue Growth (5Y)

5,83%

Revenue (1Y)4,94%

Earnings (1Y)-3,73%

FCF Growth (3Y)79,38%

Qualité

Return on Equity

4,50%

ROIC3,74%

Net Margin9,42%

Op. Margin13,08%

Sécurité

Debt / Equity

0,24

Current Ratio2,12

Interest Coverage0,00

Valorisation

P/E Ratio

37,43

Forward P/E22,40

P/B Ratio1,66

EV/EBITDA29,71

Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	4,94%	Revenue Growth (3Y)	4,88%
Earnings Growth (1Y)	-3,73%	Earnings Growth (3Y)	0,31%
Revenue Growth (5Y)	5,83%	Earnings Growth (5Y)	27,06%
Profitability
Revenue (TTM)	10,40B	Net Income (TTM)	980,00M
ROE	4,50%	ROA	3,11%
Gross Margin	55,24%	Operating Margin	13,08%
Net Margin	9,42%	Free Cash Flow (TTM)	1,73B
ROIC	3,74%	FCF Growth (3Y)	79,38%
Safety
Debt / Equity	0,24	Current Ratio	2,12
Interest Coverage	0,00
Dividends
Dividend Yield	0,00%	Payout Ratio	0,17%
Dividend Growth (3Y)	17,60%	Dividend Growth (5Y)	N/A
Consecutive Div Years	5 yrs
Valuation
P/E Ratio	37,43	Forward P/E	22,40
P/B Ratio	1,66	P/S Ratio	3,53
PEG Ratio	-11,71	Forward PEG	N/A
EV/EBITDA	29,71	Fwd EV/EBITDA	13,54
Forward P/S	3,34	Fwd Earnings Yield	4,46%
FCF Yield	4,71%
Market Cap	36,68B	Enterprise Value	40,40B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	10,40B	9,91B	9,46B	8,72B	8,29B
Net Income	980,00M	1,02B	974,00M	335,00M	376,00M
EPS (Diluted)	1,98	2,05	1,96	0,68	0,76
Gross Profit	5,75B	5,51B	5,25B	4,75B	4,65B
Operating Income	1,36B	1,41B	1,04B	672,00M	580,00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	31,56B	30,35B	29,61B	29,21B	28,00B
Total Liabilities	9,52B	8,79B	8,99B	9,53B	8,74B
Shareholders' Equity	22,03B	21,55B	20,62B	19,68B	19,26B
Total Debt	5,25B	5,14B	5,14B	5,07B	4,48B
Cash & Equivalents	1,53B	1,68B	1,09B	980,00M	1,58B
Current Assets	6,45B	6,31B	5,65B	5,19B	5,39B
Current Liabilities	3,05B	2,28B	2,40B	2,74B	2,47B